Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy

Purpose There is a need to refine the prognosis of triple-negative breast cancer (TNBC) patients after neoadjuvant chemotherapy (NAC) and to study the influence of the tumor microenvironment. We evaluated the prognostic value of pathological and immune markers in TNBC with residual disease (RD) afte...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2020, Vol.179 (1), p.11-23
Hauptverfasser:	Pinard, Clémence, Debled, Marc, Ben Rejeb, Houda, Velasco, Valérie, Tunon de Lara, Christine, Hoppe, Stéphanie, Richard, Elodie, Brouste, Véronique, Bonnefoi, Hervé, MacGrogan, Gaëtan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant treatment Analysis Breast cancer Cancer Cancer research Care and treatment CD3 antigen CD4 antigen CD8 antigen Chemotherapy Immune response Lymphocytes Medical prognosis Medical research Medicine Medicine & Public Health Medicine, Experimental Oncology Preclinical Study Prognosis Tumor-infiltrating lymphocytes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!